Comparison of varying dietary interventions in an obese population

ISRCTN ISRCTN09760867
DOI https://doi.org/10.1186/ISRCTN09760867
Secondary identifying numbers N/A
Submission date
05/09/2008
Registration date
15/09/2008
Last edited
27/01/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Iain Broom
Scientific

The Robert Gordon University
Centre for Obesity Research and Epidemiology
St. Andrew Street
Aberdeen
AB25 1HG
United Kingdom

Email j.broom@rgu.ac.uk

Study information

Study designSingle centre randomised clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleRandomised clinical trial of standard dietary treatment versus protein-sparing modified fast or the LighterLife Programme in the management of obesity
Study objectivesTo assess the effectiveness of a low carbohydrate/high protein, a commercial very low calorie diet (LighterLife) and a 600-kcal deficient diet in an obese population.
Ethics approval(s)Ethics approval received from the North of Scotland Research Ethics Service on the 3rd February 2005 (ref: 05/S0802/03).
Health condition(s) or problem(s) studiedObesity
InterventionScreening period:
600-kcal were subtracted from the subjects' estimated daily energy requirements. Portion sizes and food groups were explained to patients, who were also provided with written information. Patients were reviewed at 2, 4, 8 and 12 weeks.

Randomisation:
At the end of the screening period, patients who did not achieve a 5% weight loss were randomised to either protein-sparing modified fast (PSMF) or LighterLife (LL). PSMF patients were restricted to a maximum of 40 g of carbohydrate per day. Written information and examples of recipes were provided. The diet was supplemented with multivitamins and minerals. LighterLife is a commercial very-low calorie diet (VLCD) programme including group cognitive behaviour therapy (CBT). The programme consists of three stages: weight loss period of 100 days with VLCD provision and CBT; VLCD provision with continued counselling until target weight is achieved; 12-week weight management module with slow return to normal food and CBT. All participants were given additional lifestyle and dietary advice during 6 visits post randomisation.

These interventions were evaulated over 1 year, and patients were then followed up for 2 years.
Intervention typeOther
Primary outcome measureWeight loss, measured in kilograms before screening, at screening and 3 and 9 months post-screening.
Secondary outcome measures1. Changes in cardiovascular risk, measured by looking at total cholesterol, triacylglycerols, high density lipoprotein (HDL), low density lipoprotein (LDL), fasting glucose (all in mmol/L), fasting insulin (uU/ml), HbA1c (%) waist circumference (cm), blood pressure (mmHg)
2. Liver and kidney function; liver function assessed by measuring albumin (g/L), total bilirubin (umol/L), alkaline phosphatase, alanine aminotransferase and gamma-glutamyl transferase (U/L). For kidney function urea (mmol/L) and creatinine (umol/L) were measured and the estimated glomerular filtration was calculated.
3. Quality of life, measured using the following questionnaires: Physical activity (in house), the Dutch Eating Behaviour, the World Health Organization (WHO) quality of life, the Beck Depression Inventory, General Health, Lee fatigue scale and the Epworth Sleepiness Scale
4. Changes in adipokines

All measured before screening, at screening and 3 and 9 months post-screening.
Overall study start date03/02/2005
Completion date30/11/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Key inclusion criteria1. Men and women older than 18 years of age
2. Body Mass Index (BMI) greater than or equal to 35 kg/m^2
Key exclusion criteria1. History of hepatic or renal disease
2. Cancer
3. Current pregnancy/lactating
4. On anti-depressants or anti-obesity medication
5. Eating disorders
Date of first enrolment03/02/2005
Date of final enrolment30/11/2009

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

The Robert Gordon University
Aberdeen
AB25 1HG
United Kingdom

Sponsor information

The Robert Gordon University (UK)
University/education

Centre for Obesity Research and Epidemiology
St. Andrew Street
Aberdeen
AB25 1HG
Scotland
United Kingdom

Email j.broom@rgu.ac.uk
Website http://www.rgu.ac.uk/
ROR logo "ROR" https://ror.org/04f0qj703

Funders

Funder type

Industry

LighterLife UK Limited (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2009 Yes No